ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2022
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Aldo Bonaventura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it